SWOG clinical trial number
S9629

A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients with Advanced Pancreas Cancer

Closed
Phase
Accrual
100%
Published
Abbreviated Title
A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients with Advanced Pancreas Cancer
Activated
05/15/1997
Closed
03/15/1999

Publication Information Expand/Collapse

2014

Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single arm phase II trials

PA Philip;K Chansky;L Rubenstein;M Leblanc;L Seymour;SP Ivy;SR Alberts;PJ Catalano;J Crowley Clinical Cancer Research 20(16):4176-4185;

PMid: PMID24914040 | PMC number: PMC4296727

2002

Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study

ML Rothenberg;JK Benedetti;JS Macdonald;TE Seay;MA Neubauer;CS George;MS Tanaka Jr;JK Giguere;BT Pruitt;JL Abbruzzese Annals of Oncology 13:1576-1582